Researchers found funding for research on antimicrobial resistance pathogens has grown from $22 million in 2007 to nearly $50 million in 2009, according to a study published in Antimicrobial Resistance and Infection Control.
For this study, researchers accessed the NIH Research Portfolio Online Reporting Tools database to determine how much funding went toward research on serious healthcare-associated infections, including Staphylococcus aureus and Clostridium difficile. In addition to a major boost in funding, the researcher also discovered research on S. aureus received the greatest funding in 2009.
Despite indications that funding for antimicrobial resistance pathogens has increased, researchers found funding levels for antimicrobial resistant bacteria-related studies are lower than funding for antimicrobial resistant non-bacterial pathogens.
For this study, researchers accessed the NIH Research Portfolio Online Reporting Tools database to determine how much funding went toward research on serious healthcare-associated infections, including Staphylococcus aureus and Clostridium difficile. In addition to a major boost in funding, the researcher also discovered research on S. aureus received the greatest funding in 2009.
Despite indications that funding for antimicrobial resistance pathogens has increased, researchers found funding levels for antimicrobial resistant bacteria-related studies are lower than funding for antimicrobial resistant non-bacterial pathogens.
Related Articles on Infection Control:
Bacterial Burden on Equipment May "Rebound" After Cleaning
Study Reveals "Concerning" Disparities in Enterobacteriaceae Prevention
Alcohol Handrubs Effective But More Time Efficient Than Chlorhexidine Washing